Biotech execution partners

Startups win or lose
on time and people.

We partner with VC and PE-backed biotechs, mid and large pharma, and CDMOs at the moments that matter: IND prep, fundraising, manufacturing scale-up, and operational turnarounds.

Who we are
15-20
companies supported across the biotech journey
60+
years of combined operating experience
10+
products advanced from development through commercial launch
What we actually do

Most teams don't fail because the science isn't ready. They fail because no one is holding the execution together.

We are operators. We've been in the rooms where resources get cut mid-program and the timeline doesn't move but the milestone has to. We know which decisions compound and which problems quietly kill a company.

That's the difference between people who've consulted on biotech and people who've run it.

IND execution
Series A cell therapy. Headcount cut from 40 to 18 mid-program.
All four Redwood partners embedded. We rebuilt the execution plan and delivered the IND enabling package two months ahead of the original schedule.
Commercial launch
Oncology launch with no margin for error.
Led commercial operations and go-to-market execution. The company's share price grew 7x in the launch year.
CDMO turnaround
Cell therapy CDMO unable to release lots for Phase 2 clinical trial.
Assumed daily management of manufacturing and GMP compliance. Reduced open non-conformances by 70%, improved clinical supply by 45%, and grew revenue 5x.
Process Lock & Tech Transfer
Delivered on-time process lock and commercial-ready transfer.
We executed on-time process lock and tech transfer across multiple product segments, implemented visual management and leader standard work, and built a robust process ready for commercial scale.

Why our model works

One engagement. Four senior operators. No idle burn.

Hiring four specialists creates fixed cost you carry between milestones. A consultant gives advice without accountability. We sit in between: proven operators who flex with your needs and own the outcome.

01
Capital efficiency
Deploy proven operators immediately while you build the long-term team. Avoid severance risk, idle headcount, and the wrong hire at the wrong stage.
02
Milestone velocity
We've done this before. We know which decisions compound, which problems can wait, and how to pressure-test a plan before it costs you a quarter.
03
Flexible engagement
Project-based to fully embedded, whatever the situation calls for. We scale with your program needs, not the other way around.
The partners

You're hiring people, not a firm.

Every engagement is led by partners with direct, relevant operating experience. No analysts, no hand-offs. The people you meet are the people who do the work.

Aaron Villaroya
Aaron Villaroya
Partner
VP Operations at VC-backed cell therapy startup. Led four pipeline programs and the manufacturing facility divestiture at Atara Biotherapeutics. Kellogg MBA.
StrategyBD & CommercialOperationsClinical
Matt Guardia
Matt Guardia
Partner
Led Abzena's transformation to record revenue and profitability. VP Finance at Sastra Cell Therapy. Strategic operational plan at Enovis (Blackstone PE-backed).
FinanceHR & OperationsCDMOPE Transformation
Matt Verbrugge
Matt Verbrugge
Partner
VP Program Management at cell therapy startup. Led CMC teams for Ebvallo, the first approved allogeneic cell therapy. Nearly 20 years in program management, CMC, supply chain and strategic planning. Keck Graduate Institute MBS.
Program MgmtCMCProduct LeadershipNetwork Strategy
Josh Zimmerman
Josh Zimmerman
Partner
18+ years leading global supply chain and manufacturing across strategic and emerging biotechs. Senior Director who has built resilient supply networks for complex cell therapy operations. UCLA Anderson MBA.
Supply ChainManufacturingPartner MgmtOperational Excellence
View full bios

If the window is closing,
let's talk.

Tell us where things are. We'll be direct about whether we're the right fit, and if we are, we move fast.

Schedule a 15-minute conversation

Or email us at info@redwoodgroupca.com